Current therapeutics for COVID-19, what we know about the molecular mechanism and efficacy of treatments for this novel virus
D Narayanan, T Parimon - International journal of molecular sciences, 2022 - mdpi.com
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) has caused significant
morbidity and mortality worldwide. Though previous coronaviruses have caused substantial …
morbidity and mortality worldwide. Though previous coronaviruses have caused substantial …
Pathophysiology and treatment strategies for COVID-19
M Kumar, S Al Khodor - Journal of translational medicine, 2020 - Springer
The outbreak of Coronavirus disease of 2019 (COVID-19) caused by the Severe Acute
Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has posed a serious health threat. The …
Respiratory Syndrome coronavirus 2 (SARS-CoV-2), has posed a serious health threat. The …
Pathophysiology and potential therapeutic candidates for COVID-19: a poorly understood arena
A Samaddar, M Grover, VL Nag - Frontiers in pharmacology, 2020 - frontiersin.org
Coronavirus disease 2019 (COVID-19), an acute onset pneumonia caused by a novel
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
Betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged …
The development of COVID-19 treatment
The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …
a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest …
[HTML][HTML] Recent insight into SARS-CoV2 immunopathology and rationale for potential treatment and preventive strategies in COVID-19
As the outbreak of the new coronavirus (SARS-CoV-2) infection is spreading globally, great
effort is being made to understand the disease pathogenesis and host factors that …
effort is being made to understand the disease pathogenesis and host factors that …
Current understanding of COVID-19 clinical course and investigational treatments
RB Aguilar, P Hardigan, B Mayi, D Sider… - Frontiers in …, 2020 - frontiersin.org
Importance: Currently, there is no unified framework linking disease progression to
established viral levels, clinical tests, inflammatory markers, and investigational treatment …
established viral levels, clinical tests, inflammatory markers, and investigational treatment …
Management of COVID-19: A brief overview of the various treatment strategies
B Qayyumi, A Singh, V Tuljapurkar… - Cancer Research …, 2020 - journals.lww.com
Background: Coronavirus disease 2019 (COVID-19) has posed a new challenge to the
entire world. Many speculations revolve around its treatment. Numerous theories have been …
entire world. Many speculations revolve around its treatment. Numerous theories have been …
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2)
Y Song, M Zhang, L Yin, K Wang, Y Zhou… - International journal of …, 2020 - Elsevier
Currently, there is no approved therapy for coronavirus disease 2019 (COVID-19). The
World Health Organization (WHO) therefore endorses supportive care only. However …
World Health Organization (WHO) therefore endorses supportive care only. However …
Cytokines and chemokines in SARS-CoV-2 infections—therapeutic strategies targeting cytokine storm
A Pum, M Ennemoser, T Adage, AJ Kungl - Biomolecules, 2021 - mdpi.com
The recently identified severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
virus, the cause of coronavirus disease (COVID-19) and the associated ongoing pandemic …
virus, the cause of coronavirus disease (COVID-19) and the associated ongoing pandemic …
Contemporary narrative review of treatment options for COVID‐19
L Shang, DC Lye, B Cao - Respirology, 2021 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) pandemic is ongoing and many drugs
have been studied in clinical trials. From a pathophysiological perspective, anti‐viral drugs …
have been studied in clinical trials. From a pathophysiological perspective, anti‐viral drugs …